A detailed history of Us Bancorp \De\ transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 400 shares of ANIX stock, worth $1,032. This represents 0.0% of its overall portfolio holdings.

Number of Shares
400
Previous 400 -0.0%
Holding current value
$1,032
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

SELL
$2.55 - $4.1 $33,784 - $54,320
-13,249 Reduced 97.07%
400 $1,000
Q1 2022

May 11, 2022

BUY
$2.5 - $3.42 $33,122 - $45,311
13,249 Added 3312.25%
13,649 $37,000
Q4 2021

Feb 11, 2022

BUY
$2.88 - $5.5 $1,152 - $2,200
400 New
400 $1,000

Others Institutions Holding ANIX

About Anixa Biosciences Inc


  • Ticker ANIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,661,700
  • Market Cap $79.1M
  • Description
  • Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...
More about ANIX
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.